Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 EUR | -.--% | -3.39% | +26.67% |
May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
Mar. 28 | Transcript : Malin Corporation plc - Shareholder/Analyst Call |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 207.7 | 188.4 | 292.4 | 246.8 | 84.63 | 107.7 | - | - |
Enterprise Value (EV) 1 | 207.7 | 216.1 | 292.4 | 72.91 | 55.33 | 79.54 | 80.82 | 82.19 |
P/E ratio | - | - | 7.88 x | - | - | - | - | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 5,951,457 x | 4,594,589 x | - | - | - | - | - | - |
EV / Revenue | 5,951,457 x | 5,270,199 x | - | - | - | - | - | - |
EV / EBITDA | - | -9.65 x | - | - | -12.9 x | -26.5 x | -26.9 x | -27.4 x |
EV / FCF | - | -63.6 x | - | - | -17.3 x | -74 x | -63.4 x | -59.8 x |
FCF Yield | - | -1.57% | - | - | -5.78% | -1.35% | -1.58% | -1.67% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 45,750 | 45,946 | 43,635 | 33,996 | 18,806 | 18,889 | - | - |
Reference price 2 | 4.540 | 4.100 | 6.700 | 7.260 | 4.500 | 5.700 | 5.700 | 5.700 |
Announcement Date | - | 3/23/21 | 3/15/22 | 2/16/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales | 34.9 | 41 | - | - | - | - | - | - |
EBITDA 1 | - | -22.4 | - | - | -4.3 | -3 | -3 | -3 |
EBIT 1 | - | -22.4 | - | - | -4.5 | -3 | -3 | -3 |
Operating Margin | - | -54.63% | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | 91 | - | - | - | -2 | -2.2 | -2.3 |
Net income | - | - | 37.8 | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - |
EPS | - | - | 0.8500 | - | - | - | - | - |
Free Cash Flow 1 | - | -3.4 | - | - | -3.2 | -1.075 | -1.275 | -1.375 |
FCF margin | - | -8.29% | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | - | 3/23/21 | 3/15/22 | 2/16/23 | 2/28/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | 27.7 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | 174 | 29.3 | 28.1 | 26.9 | 25.5 |
Leverage (Debt/EBITDA) | - | -1.237 x | - | - | - | - | - | - |
Free Cash Flow 1 | - | -3.4 | - | - | -3.2 | -1.08 | -1.28 | -1.38 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | - | 3/23/21 | 3/15/22 | 2/16/23 | 2/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.67% | 117M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- MLC Stock
- Financials Malin Corporation plc